Department of Pediatrics, University of Iowa, Iowa City, Iowa, USA.
Department of Neonatology, Liverpool Women's Hospital, Liverpool, UK.
Pediatr Pulmonol. 2021 May;56(5):982-991. doi: 10.1002/ppul.25252. Epub 2021 Jan 12.
Approximately 40% of hypoxemic term/near-term neonates are nonresponders to inhaled nitric oxide (iNO). Phenotypic characterization of patients less likely to respond may improve diagnostic precision and therapeutic decisions. We conducted a retrospective cohort study of neonates born ≥35 weeks gestation with hypoxemia who received iNO in the first 72 h of life and classified them into responders and nonresponders according to changes in the fraction of inspired oxygen, saturations and/or arterial partial pressure of oxygen after 1 h of administration. Comprehensive targeted neonatal echocardiography (TnECHO) data were collected when performed up to 6 h prior or 24 h after iNO initiation. Descriptive statistics, univariate analysis, and binary logistic regression were used to compare the groups. There were 183 patients included (63% responders) and TnECHO was performed in 54 infants. The presence of lung disease, and particularly meconium aspiration syndrome (p = .004), was associated with nonresponse to iNO. Nonresponders were characterized by a higher need for rescue high-frequency ventilation (p < .001), longer duration of mechanical ventilation (p < .001), and need for oxygen support (p = .003). Pulmonary hypertension documented on TnECHO was present in 96.3% of the patients but there was no difference in frequency or severity of pulmonary hypertension, or rates of low cardiac output between the groups. Moderate-to-severe right ventricular systolic dysfunction (p > .05) and lower left ventricular strain (p < .05) were more likely in the nonresponder group. In summary, response to iNO is influenced by lung disease, choice of ventilation strategy, and perhaps underlying cardiovascular physiology. Prospective pre- and post-iNO echocardiography data may provide novel physiologic insights.
大约 40%的低氧血症足月/近足月新生儿对吸入性一氧化氮(iNO)无反应。对不太可能有反应的患者进行表型特征分析可能会提高诊断精度和治疗决策。我们对出生胎龄≥35 周、出生后 72 小时内接受 iNO 治疗且接受 iNO 治疗 1 小时后吸氧分数、饱和度和/或动脉血氧分压变化的患者进行了回顾性队列研究,并根据这些变化将患者分为反应者和无反应者。在开始使用 iNO 之前最多 6 小时或之后 24 小时内进行全面的新生儿超声心动图(TnECHO)数据采集。采用描述性统计、单变量分析和二项逻辑回归对两组进行比较。共纳入 183 例患者(63%为反应者),其中 54 例进行了 TnECHO。肺疾病,特别是胎粪吸入综合征(p=0.004)与 iNO 无反应相关。iNO 无反应者的特点是需要更高的高频通气(p<0.001)、更长的机械通气时间(p<0.001)和需要氧支持(p=0.003)。TnECHO 证实存在肺动脉高压的患者占 96.3%,但两组之间肺动脉高压的频率和严重程度或低心输出率无差异。中度至重度右心室收缩功能障碍(p>0.05)和左心室应变较低(p<0.05)在无反应组中更常见。总之,iNO 的反应受到肺部疾病、通气策略的选择以及潜在的心血管生理学的影响。iNO 前后的前瞻性超声心动图数据可能提供新的生理学见解。